2/26
10:40 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
2/26
10:40 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
2/23
09:00 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock, up previously from $12.00.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock, up previously from $12.00.
2/23
09:00 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock, up previously from $12.00.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock, up previously from $12.00.
2/23
08:46 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
1/29
07:08 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $6.00 price target on the stock.
High
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $6.00 price target on the stock.
1/29
05:43 am
cccc
Rating for CCCC
High
Report
Rating for CCCC